Recital 13, Commission Regulation (EU) No 1138/2013 of 8 November 2013 amending Annexes II, III and…

In forcesince 8 Nov 2013

For vinclozolin, the model established by the Authority to assess acute and chronic risk [http://www.efsa.europa.eu/en/mrls/docs/calculationacutechronic_2.xls] shows that a high level of consumer protection is maintained. This Regulation should therefore provide for a transitional arrangement, in order to allow normal marketing, processing and consumption of products which have been lawfully produced before the application of this Regulation.